Bio-Techne Corp (FRA:TE1)
€ 76.5 1 (1.32%) Market Cap: 11.96 Bil Enterprise Value: 12.28 Bil PE Ratio: 65.48 PB Ratio: 6.45 GF Score: 92/100

Bio-Techne Corp at Evercore ISI HealthCONx Conference (Virtual) Transcript

Nov 29, 2022 / 01:50PM GMT
Release Date Price: €79 (-0.63%)
Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - Senior MD and Head of Medical Supplies & Devices and Life Science Tools & Diagnostics Team

Okay. Thanks, everyone, for joining us this morning. We're kicking off the Life Sciences -- on the Life Sciences side, but biotech, a pleasure to have with us the management team. We have the CEO, Chuck Kummeth, we have CFO, Jim Hippel, with us. We also have the President of our Protein Sciences Will Geist and from Investor Relations, David Clair. So with that, Chuck and Jim, thanks for taking the time for being with us this morning.

Charles R. Kummeth
Bio-Techne Corporation - CEO, President & Director

Sure.

Questions & Answers

Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - Senior MD and Head of Medical Supplies & Devices and Life Science Tools & Diagnostics Team

So I wanted to start with -- this -- the last quarter, this was unusual for biotech. You guys are known as one of the high

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot